USPTO serial 99112527
ONCOMATCH
Reviewed by CopyMark Law Group
Status 730Notice of Allowance
- Filing date
- Status date
- Registration date
- —
- Examiner
- DUFFIN, GRACE M
- Law office
- INTENT TO USE SECTION
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Need help with ONCOMATCH?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $947*
Plus Government fees of $450
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Kevin Oliver
Kevin Oliver Revvity, Inc.77 4th AvenueWaltham, MA 02451United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Biological preparations for use in industry and science specifically for use in research laboratories, biopharmaceutical and research purposes specifically as reference standards; Biological preparations for use in industry and science specifically cancer research; Biological preparations for use in industry and science specifically for use in quality control applications; Biological preparations for use in industry and science specifically cultured ex vivo cell lines for use as reference standards for research purpose; Samples being biological preparations for use in industry and science specifically for biochemical or biological laboratory analysis for research purposes; Cell line-derived products namely, reagents for scientific and research purposes specifically for clinical investigations and for use in product testing; Reference standards being reagents used for research purposes, namely, next generation sequencing, droplet-digital, Real-Time PCR or Sanger sequencing; | ACTIVE | — |
| 005 | cell line-derived reference standards used in clinical samples in the nature of biological preparations for use in cell cultures for medical purposes; Reference standard substances being reagents used for clinical tests for medical purposes; Reference standards being reagents used for next generation DNA sequencing and/or Polymerase chain reaction (PCR) testing for medical purposes; Reference standards being diagnostic preparations for medical purposes specifically for detecting chromosomal abnormalities; Reference standards being diagnostic preparations for medical purposes specifically for analyzing biological samples for medical purposes | ACTIVE | — |
| 040 | Custom manufacture of cell line-delivered products being biological preparations for medical and commercial applications; Custom manufacture of reference standards being biological preparations for use in industry and science | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Revvity Discovery Limited
- Other trademarks owned by Revvity Discovery Limited
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 040
- Similar marks named ONCOMATCH
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 13, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Oct 12, 2026 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Oct 12, 2026 | EXT1 | SOU EXTENSION 1 FILED | — |
| Oct 12, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Apr 14, 2026 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Feb 17, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 17, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 11, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 23, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 23, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 23, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 23, 2026 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Nov 11, 2025 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Nov 11, 2025 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Nov 11, 2025 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Oct 14, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 14, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 14, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 13, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 13, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 13, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 7, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 6, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 31, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 31, 2025 | NWAP | NEW APPLICATION ENTERED | — |